Authors:
Tardivel-Lacombe, J
Morisset, S
Gbahou, F
Schwartz, JC
Arrang, JM
Citation: J. Tardivel-lacombe et al., Chromosomal mapping and organization of the human histamine H-3 receptor gene, NEUROREPORT, 12(2), 2001, pp. 321-324
Authors:
Schwartz, JC
Morisset, S
Rouleau, A
Tardivel-Lacombe, J
Gbahou, F
Ligneau, X
Heron, A
Sasse, A
Stark, H
Schunack, W
Ganellin, RC
Arrang, JM
Citation: Jc. Schwartz et al., Application of genomics to drug design: the example of the histamine H-3 receptor, EUR NEUROPS, 11(6), 2001, pp. 441-448
Authors:
Sasse, A
Ligneau, X
Sadek, B
Elz, S
Pertz, HH
Ganellin, CR
Arrang, JM
Schwartz, JC
Schunack, W
Stark, H
Citation: A. Sasse et al., Benzophenone derivatives and related compounds as potent histamine H-3-receptor antagonists and potential PET/SPECT ligands, ARCH PHARM, 334(2), 2001, pp. 45-52
Authors:
Stark, H
Ligneau, X
Sadek, B
Ganellin, CR
Arrang, JM
Schwartz, JC
Schunack, W
Citation: H. Stark et al., Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H-3-receptor antagonists, BIOORG MED, 10(20), 2000, pp. 2379-2382
Authors:
Tardivel-Lacombe, J
Rouleau, A
Heron, A
Morisset, S
Pillot, C
Cochois, V
Schwartz, JC
Arrang, JM
Citation: J. Tardivel-lacombe et al., Cloning and cerebral expression of the guinea pig histamine H-3 receptor: evidence for two isoforms, NEUROREPORT, 11(4), 2000, pp. 755-759
Authors:
Drutel, G
Kathmann, M
Heron, A
Gros, C
Mace, S
Schwartz, JC
Arrang, JM
Citation: G. Drutel et al., Two splice variants of the hypoxia-inducible factor HIF-1 alpha as potential dimerization partners of ARNT2 in neurons, EUR J NEURO, 12(10), 2000, pp. 3701-3708
Authors:
Morisset, S
Rouleau, A
Ligneau, X
Gbahou, F
Tardivel-Lacombe, J
Stark, H
Schunack, W
Ganellin, CR
Schwartz, JC
Arrang, JM
Citation: S. Morisset et al., High constitutive activity of native H-3 receptors regulates histamine neurons in brain, NATURE, 408(6814), 2000, pp. 860-864
Authors:
Stark, H
Sadek, B
Krause, M
Huls, A
Ligneau, X
Ganellin, CR
Arrang, JM
Schwartz, JC
Schunack, W
Citation: H. Stark et al., Novel histamine H-3-receptor antagonists with carbonyl-substituted 4-(3-(phenoxy)propyl)-1H-imidazole structures like ciproxifan and related compounds, J MED CHEM, 43(21), 2000, pp. 3987-3994
Authors:
Sasse, A
Sadek, B
Ligneau, X
Elz, S
Pertz, HH
Luger, P
Ganellin, CR
Arrang, JM
Schwartz, JC
Schunack, W
Stark, H
Citation: A. Sasse et al., New histamine H-3-receptor ligands of the proxifan series: Imoproxifan andother selective antagonists with high oral in vivo potency, J MED CHEM, 43(17), 2000, pp. 3335-3343
Authors:
Ligneau, X
Morisset, S
Tardivel-Lacombe, J
Gbahou, F
Ganellin, CR
Stark, H
Schunack, W
Schwartz, JC
Arrang, JM
Citation: X. Ligneau et al., Distinct pharmacology of rat and human histamine H-3 receptors: role of two amino acids in the third transmembrane domain, BR J PHARM, 131(7), 2000, pp. 1247-1250
Authors:
Morisset, S
Sahm, UG
Traiffort, E
Tardivel-Lacombe, J
Arrang, JM
Schwartz, JC
Citation: S. Morisset et al., Atypical neuroleptics enhance histamine turnover in brain via 5-hydroxytryptamine(2A) receptor blockade, J PHARM EXP, 288(2), 1999, pp. 590-596
Authors:
Arrang, JM
Morisset, S
Pillot, C
Schwartz, JC
Citation: Jm. Arrang et al., Subclassification of histamine receptors, H-3-receptor subtypes? Localization of H-3 receptors in the brain, PHARMCHEM L, 30, 1998, pp. 1-12